StockGlow

NextCell Pharma AB (NXTCL.ST)

NextCell Pharma AB, a biopharmaceutical company, engages in the research, development, and manufacture of stromal cell therapies in Sweden.

1.13+0.01%Healthcare
Compare NXTCL.ST with
StockGlow Score
73
Leaning Bullish
BearishBullish
1 year ago-3.9%

The outlook

NextCell Pharma AB currently reads as leaning bullish based on above its 50- & 200-day averages, 43% of the way from its 52-week low to high, avg target +211% vs current price. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range43% of the way from its 52-week low to high
Price targetAvg target +211% vs current price
Market cap
$125.4M
52-wk high
1.78
52-wk low
0.63
50-day avg
1.08
200-day avg
1.08
Trailing P/E
—

Similar stocks

DMYD-B.STDiamyd Medical AB (publ)$1.03+0.00%VICO.STVicore Pharma Holding AB (publ)$11.12+0.91%CANTA.STCantargia AB (publ)$1.82+0.33%ACE.STAscelia Pharma AB (publ)$0.53+4.51%IMMNOV.STImmunovia AB (publ)$0.18-0.77%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy